With respect to increased LDs in response to exogenous supplementation with oleic acid, this cellular response appears to be similar to that with fatty acid synthase (FAS) inhibitors along with mTOR inhibitors which results in synergistic toxicity in breast cancer cells. The gene discussed is FASN; the disease is breast cancer.